ARCHIVES

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

Pitot Named New NCAB Chairman

May 4, 1979

Congressional Committees Add Provisions To Cancer Act Renewal Bills To Strengthen NCI’s Independence, Prevent Fund Withholding

March 8, 1974

Tacoma Hospital Finds Cancer DRGs Are Profitable

February 17, 1984

NCI Expects Centers To Increase Cancer Control Efforts Despite Various Obstacles They Face

January 16, 1987

MEPACT Approved In Europe For Resectable Osteosarcoma

March 27, 2009

Senate Report Calls on NCI To Expand Research in Survivorship, CAM, GYN Cancers, And Fund Five Pancreatic SPOREs

August 2, 2002